Education
-
Gratuated at secondary school focusing on
science “Albert Einstein”, Rimini, Italy, with 60/60 in 1997
-
Predoctoral training at Medical
School of Cardiology, Institute of Cardiology, University of
Bologna since 2002.
-
Graduate, MD, 110/110 cum laude, 24
October 2003, Medical Faculty, University of
Bologna.
-
Medical license from 06/Jul/2004
(Rimini)
-
Graduate, Cardiologist, 70/70 cum
laude in 5 November 2007, Institute of Cardiology, University of
Bologna.
-
PhD in Cardiology (Institute of
Cardiology University
of Bologna) obtained in 25/May/2011
-
University researcher since
01/June/2013
Papers
1.
A
Manes, M Palazzini, L Negro,
S Romanazzi, F
Pelino, K Vaziri Farahani, G Boggian, G Vassiliki Coutsoumbas, N
Galiè, A Branzi. “Caratteristiche cliniche, emodinamiche e
prognostiche dei pazienti affetti da ipertensione arteriosa
polmonare associata a sindrome Crest”. Ital Heart J
2003;4(6):110S
2.
A
Manes, L Negro, F
Pelino, G Boggian, S
Romanazzi, K Vaziri Farahani, M Palazzini, G Vassiliki
Coutsoumbas, N Galiè, A Branzi. “Analisi critica del test di
vasoreattività polmonare nei pazienti con ipertensione arteriosa
polmonare”. Ital Heart J
2003;4(6):109S
3.
A. Manes, L.
Negro, K. Vaziri Farahani, F. Pelino, M. Palazzini, S.
Romanazzi, N. Galiè, A. Branzi “Effetti clinici ed emodinamici del
trattamento con Sildenafil nei pazienti con ipertensione arteriosa
polmonare” Ital Heart J 2004; 5(9):139S
4.
K. Vaziri
Farahani, G. Boggian, A. Manes, F. Pelino, S. Romanazzi, M. Palazzini, L. Negro, N.
Galiè, A. Branzi “Effetti a lungo termine del trattamento con
Bosentan sulla capacità funzionale e sui parametri emodinamici nei
pazienti con ipertensione arteriosa polmonare” Ital Heart J
2004; 5(9):201S
5.
K. Vaziri
Farahani, S. Gambetti, A.Marinelli, E. Leci, S. Romanazzi, M. Palazzini, L. Negro, L.
Presotto, A. Manes, N. Galiè, A. Branzi “ Confronto tra
antagonisti recettoriali selettivi e non selettivi dall'endotelina
nel trattamento dell'ipertensione arteriosa polmonare”.
Ital Heart J 2005; 6(8): 85S
6.
A. Manes, G.
Rocchi, M. Ferlito, K. Vaziri Farahani, S. Romanazzi, L. Negro,
M. Palazzini, L.
Presotto, A. Marinelli, S. Gambetti, E. Leci, N. Galiè, A. Branzi “
Significato prognostico dell'area del rigurgito tricuspidalico nei
pazienti con ipertensione polmonare idiopatica trattati secondo le
attuali linee guida”. Ital Heart J 2005; 6(8):
85S
7.
M. Palazzini, A. Manes, A. Marinelli, E. Leci, S.
Gambetti, L. Presotto, L. Negro, K. Vaziri Farahani, S. Romanazzi, N. Galiè,
A. Branzi “Complicanze del cateterismo cardiaco destro in pazienti
con ipertensione polmonare precapillare di grado severo” Ital
Heart J 2005; 6(8): 174S
8.
L. Negro, A.
Manes, E. Leci, S. Gambetti, A, Marinelli, L. Presotto, S. Romanazzi, K. Vaziri
Farahani, M. Palazzini,
N. Galiè, A. Branzi “Il test acuto di vasoreattività nei pazienti
con ipertensione arteriosa polmonare” Ital Heart J 2005;
6(8): 174S
9.
K. Vaziri
Farahani, S.
Romanazzi, M.
Palazzini, L. Negro, L. Presotto, A. Marinelli, S. Gambetti, E.
Leci, A. Manes, N. Galiè, A. Branzi “Regressione delle alterazioni
elettrocardiografiche indicative, di ipertrofia ventricolare destra
nei pazienti con ipertensione arteriosa polmonare” Ital Heart J
2005; 6(8): 174S
10.
S.
Romanazzi, A. Manes, S.
Gambetti, A. Marinelli, E. Leci, L. Negro, K. Vaziri
Farahani, M. Palazzini,
L. Presotto, N. Galiè, A. Branzi “Effetti del trattamento con
Sildenafil nei pazienti con ipertensione arteriosa polmonare
idiopatica, associata e cuore polmonare cronico tromboembolico”
Ital Heart J 2005; 6(8): 247S
11.
A. Manes, L. Negro, K. Vaziri
Farahani, F. Pelino, S.
Romanazzi, M.
Palazzini, N. Galiè, A. Branzi “Long-term efficacy and safety
of sildenafil in precapillary pulmonary hypertension” EHJ
2005; vol 26 (Abstracts supplement): 78
12.
N. Galiè, A. Manes, K.V. Farahani, F. Pelino, M. Palazzini, L. Negro,
S. Romanazzi, A.
Branzi “Pulmonary arterial hypertension associated to connettive
tissue disease” Lupus (2005) 14, 713-717
13.
Bertoni M, Niccoli L, Porciello G, Storri L, Nannini C, Manes A, Palazzini M, Galie N,
Cantini F. “Pulmonary hypertension in primary Sjogren's syndrome:
report of a case and review of the literature.” Clin
Rheumatol. 2005 Aug;24(4):431-4. Epub 2005 May 19. Review.
PMID: 15906110
14.
A.
Manes, N. Galiè, M.
Palazzini, S.
Romanazzi, L. Presotto, L. Negro, T. Ionico, A. Branzi
“Reverse remodelling of ECG changes in idiopathic pulmonary
hypertension patients responders to chronic treatment with calcium
channel blokers” EHJ 2006; vol 27 (Abstracts supplement):
619
15.
M. Palazzini, L. Presotto, S. Romanazzi, T. Ionico,
L. Negro, S. Gambetti, A. Marinelli, E. Leci, M. Grossi, A. Manes,
N. Galiè, A. Branzi “Risposta emodinamica allo sforzo nei pazienti
con ipertensione arteriosa polmonare” Ital Heart J 2006;
7(1-12): 20S
16.
S.
Romanazzi, L. Presotto,
M. Palazzini, L. Negro,
T. Ionico, A. Marinelli, S. Gambetti, E. Leci, M. Grossi, G.
Albanese, A. Manes, N. Galiè, A. Branzi “Effetti del trattamento
con Sildenafil nei pazienti affetti da ipertensione arteriosa
polmonare associata ad infezione da HIV” Ital Heart J 2006;
7(1-12): 63S
17.
M. Grossi, M. Palazzini, A. Manes, L.
Presotto, L. Negro, T. Ionico, S. Romanazzi, E. Leci, A.
Marinelli, S. Gambetti, N. Galiè, A. Branzi “Sopravvivenza a lungo
termine dei pazienti con ipertensione arteriosa polmonare trattati
con Bosentan” Ital Heart J 2006; 7(1-12):
67S
18.
L. Presotto, M. Palazzini, S. Romanazzi, L. Negro,
T. Ionico, A. Marinelli, E. Leci, S. Gambetti, M. Grossi, A. Manes,
N. Galiè, A. Branzi “Transizione rapida da Epoprostenolo endovena a
Treprostinil endovena in pazienti con ipertensione arteriosa
polmonare” Ital Heart J 2006; 7(1-12):
102S
19.
T. Ionico, L.
Presotto, S.
Romanazzi, M.
Palazzini, L. Negro, A. Marinelli, S. Gambetti, E. Leci, M.
Grossi, G. Albanese, A. Manes, N. Galiè, A. Branzi “Il BNP
plasmatici nei pazienti con ipertensione arteriosa polmonare è
correlato con i parametri funzionali ed emodinamici” Ital Heart J 2006;
7(1-12): 202S
20.
L. Negro, S. Romanazzi, L.
Presotto, M. Palazzini,
T. Ionico, A. Marinelli, S. Gambetti, E. Leci, M. Grossi, G.
Albanese, A. Manes, N. Galiè, A. Branzi “Effetti del trattamento
con Sildenafil nei pazienti affetti da cuore polmonare cronico
tromboembolico” Ital Heart J 2006; 7(1-12):
202S
21.
S.
Romanazzi, L. Presotto,
M. Palazzini, L. Negro,
T. Ionico, A. Marinelli, S. Gambetti, E. Leci, M. grossi, G.
Albanese, A. Manes, N. Galiè, A. Branzi “Effetti del trattamento
con Sildenafil nei pazienti affetti da sindrome di Eisenmenger”
Ital Heart J 2006; 7(1-12): 202S
22.
Hoeper MM, Lee SH, Voswinckel R, Palazzini M, Jais X,
Marinelli A, Barst RJ, Ghofrani HA, Jing ZC, Opitz C, Seyfarth HJ,
Halank M, McLaughlin V, Oudiz RJ, Ewert R, Wilkens H, Kluge S,
Bremer HC, Baroke E, Rubin LJ. “Complications of right heart catheterization
procedures in patients with pulmonary hypertension in experienced
centers.” J Am Coll Cardiol. 2006 Dec 19;48(12):2546-52. Epub 2006
Nov 28. PMID: 17174196
23.
O. Sitbon, A. Manes, X. Jais, M. Palazzini, M. Humbert,
L. Presotto, L. De Pailette, D. Zaccardelli, G. Davis, R. Jeffs, G.
Simonneau, N. Galiè. Rapid Switch from intravenous epoprostenol to
intravenous treprostinil in patients with pulmonary arterial
hypertension.
J Cardiovasc Pharmacol. 2007 Jan;49(1):1-5.
24.
A. Manes, N.
Galiè, M. Palazzini, S.
Romanazzi, L. Presotto, L. Negro, T. Ionico, A. Branzi.
“Reverse remodelling of ECG changes in
idiopathic pulmonary arterial hypertension patient responders to
chronic treatment with calcium channel blockers” Polish Heart Journal, Volume
64, Supplement I, P B30
25.
S. Romanazzi, A. Manes, N. Hirani,
M. Palazzini, L.
Presotto, E. Leci, M. Grossi, N. Galiè “Sildenafil therapy for
patients with pulmonary arterial hypertension Associated with HIV
infection” Am J Resp and
Crit Care Med 2007; vol 175: A301
26.
A. Manes, S. Romanazzi, N. Hirani,
M. Palazzini, L.
Presotto, E. Leci, M. Grossi, N. Galiè “Sildenafil therapy in
patients with Eisenmenger Syndrome” Am J Resp and Crit Care Med
2007; vol 175: A301
27.
N.
Hirani, S. Romanazzi, A. Manes, M. Palazzini, L. Presotto,
E. Leci, M. Grossi, N. Galiè “Sildenafil therapy for patients with
inoperable chronic thromboembolic pulmonary hypertension” Am J Resp and Crit Care Med
2007; vol 175: A301
28.
N. Hirani, A. Manes, S. Romanazzi,
M. Palazzini, L.
Presotto, E. Leci, M. Grossi, N. Galiè “Effects of first-line
Bosentan therapy on survival in patients with pulmonary arterial
hypertension” Am J Resp and
Crit Care Med 2007; vol 175: A397
29.
M. Palazzini, T. Ionico,
A. Manes, S. Romanazzi,
N. Hirani, L. Presotto, E. Leci, M. Grossi, N. Galiè “Plasma nt-BNP
in patients with heterogeneous causes of pulmonary hypertension
correlate with functional and hemodynamic parameters” Am J Resp and Crit Care Med
2007; vol 175: A716
30.
M.
Palazzini, A.
Manes, S. Romanazzi, S.
Gambetti, E. Leci, M. Grossi, L. Negro, T. Ionico, A. Branzi, N.
Galiè “Effects of Sildenafil treatment in patients with pulmonary
hypertension associated with congenital cardiac shunts” EHJ 2007, vol 28 (abstracts
supplement): 308
31.
M. Grossi, M. Palazzini, A. Manes, E.
Leci, S. Romanazzi, L.
Presotto, L. Negro, A.
Marinelli, A. Branzi, N. Galiè “Results of aggressive follow-up
strategy in patients with pulmonary arterial hypertension” EHJ 2007, vol 28 (abstracts
supplement): 308
32.
S. Romanazzi, A. Manes, M. Palazzini, T. Ionico,
E. Leci, L. Negro, M. Grossi, A. Marinelli, A.
Branzi, N. Galiè “Effects of Sildenafil treatment in patients with
chronic thromboembolic pulmonary hypertension” EHJ 2007, vol 28 (abstracts
supplement): 632
33.
N. Hirani, A. Manes, C.
Parravicini, C. Scalamogna, M. Palazzini, L. Negro, S.
Romanazzi, E. Longhi,
G. Bestetti, R. Piolin,
G. Lunghi, A. Orlandi, A. Branzi, M. Corbellino, N. Galiè “Evidence
for Kaposi's sarcoma-associated herpes virus infection in patients
with idiopathic pulmonary arterial hypertension: a case series and
review of the literature” Curr Med Res and Op, vol
23, suppl 2, May 2007, pp 83-87(5)
34.
N. Galiè, N. Hirani, A. Manes, S.
Romanazzi, M. Palazzini, L. Negro, A.
Branzi “Long term therapeutic outcomes in pulmonary arterial
hypertension” Curr Med Res
and Op, vol 23, suppl 2, May 2007, pp s11-s18
35.
A. Manes, M. Ferlito, G. Rocchi,
L. Bacchi-Reggiani, N. Hirani, S. Romanazzi, M. Palazzini, L. Negro, A.
Branzi and N. Galiè “Left ventricular dimensions in pulmonary
arterial hypertension: haemodinamic and exercise correlations” Curr Med Res and Op, vol
23, suppl 2, May 2007, pp s55-s62
36.
Galie N, Manes A, Palazzini
M et al. “Pharmacological impact on right ventricular
remodelling in pulmonary arterial hypertension”. Eur Heart J Suppl
2007; 9(suppl_H):H68-H74
37.
L.
Negro, M. Zavatta, C. Bachetti, E. Beciani, M. Palazzini, S.
Romanazzi, E. Leci, M. Grossi, A. Marinelli, S. Gambetti, A. Manes,
N. Galiè, A. Branzi “Effetti a lungo termine del sildenafil in
soggetti con ipertensione arteriosa polmonare e cuore polmonare
cronico tromboembolico” Ital Heart J 2007; 8 (1-12): C173
38.
S.
Romanazzi, E. Beciani, M.
Palazzini, L. Negro, C. Bachetti, M. Grossi, E. Leci, A.
Marinelli, S. Gambetti, M. Zavatta, A. Manes, N. Galiè, A. Branzi
“Effetti a lungo termine del trattamento con sildenafil nei
pazienti affetti da ipertensione arteriosa polmonare associata a
cardiopatie congenite con shunt” Ital Heart J
2007; 8 (1-12):
C171
39.
M. Palazzini, C. Bachetti, L. Negro, S.
Romanazzi, A. Marinelli, S. Gambetti, M. Zavatta, E. Beciani, E.
leci, M. Grossi, A. Manes, N. Galiè, A. Branzi “Andamento clinico,
emodinamico e dei livelli plasmatici dell'NT- pro BNP in paziente
con ipertensione arteriosa polmonare precapillare” Ital Heart J
2007; 8 (1-12): C292
40.
L. Negro, M. Palazzini, S.
Romanazzi, A. Manes, E. Leci, M. Grossi, C. Bachetti, E. Beciani,
A. Marinelli, N. Galiè “Changes of NT-pro BNP plasma concentration
correlate with changes of functional and hemodynamic parameters in
patients with eterogeneous causes of pulmonary hypertension” Am J Resp and Crit Care Med
2008; vol 177: A920
41.
M. Palazzini, S.
Romanazzi, A. Manes, L. Negro, E. Leci, A. Marinelli, S. Gambetti,
M. Grossi, E. Beciani, N. Galiè “Sildenafil therapy for patients
with porto-pulmonary hypertension” Am J Resp and Crit Care Med
2008; vol 177: A696
42.
S. Romanazzi, N. Hirani, M. Palazzini, L. Negro, A.
Manes, M. Grossi, C. Bachetti, E. Beciani, N. Galiè “Survival with
first-line sildenafil therapy in patients with pulmonary arterial
and chronic thromboembolic pulmonary hypertension” Am J Resp and Crit Care Med
2008; vol 177: A260
43.
S. Gambetti, M. Palazzini, A.
Marinelli, L. Negro, E. Leci, E. Beciani, E. Conficoni, A. Manes,
A. Branzi, N. Galiè “Epidemiology of patient referred to a
specialised pulmonary hypertension center” Ital Heart J
2008; 9 (1-12): C74
44.
L. Negro, M. Palazzini, A.
Marinelli, E. Conficoni, S. Gambetti, E. Leci, E. Beciani, A.
Manes, A. Branzi, N. Galiè “Effetti del sildenafil in soggetti con
cuore polmonare cronico tromboembolico” Ital Heart J 2008; 9
(1-12): C76
45.
A. Marinelli, S.
Gambetti, E. Conficoni, M.
Palazzini, L. Negro, E. Leci, C. Bachetti, A. Manes, A. Branzi,
N. Galiè “Sildenafil therapy in patients with porto-pulmonary
hypertension” Ital Heart J 2008; 9 (1-12):
C317
46.
E. Conficoni, L.
Negro, S. Gambetti, A. Marinelli, C. Bachetti, E. Leci, M. Palazzini, A. Manes, A.
Branzi, N. Galiè “Effetti emodinamici e funzionali
dell'epoprostenolo in associazione agli antagonisti recettoriali
dell'endotelina e agli inibitori delle fosfodiesterasi-5” Ital Heart J 2008; 9
(1-12): C318
47.
M. Palazzini, L. Negro, E. Conficoni, A.
Marinelli, S. Gambetti, E. Leci, C. Bachetti, A. Manes, A. Branzi,
N. Galiè “Experience eith inheritable pulmonary arterial
hypertension in a specialised center” Ital Heart J 2008; 9
(1-12): C322
48.
Galie N, Manes A, Palazzini
M, Negro L, Marinelli A, Gambetti S, Mariucci E, Donti A,
Branzi A, Picchio FM. “Management of pulmonary arterial hypertension
associated with congenital systemic-to-pulmonary shunts and
Eisenmenger's syndrome” Drugs. 2008;68(8):1049-66
49.
Galiè N, Manes A, Negro L, Palazzini M,
Bacchi-Reggiani ML, Branzi A. A meta-analysis of randomized
controlled trials in pulmonary arterial hypertension. Eur Heart J.
2009 Feb;30(4):394-403. Epub 2009 Jan 20
50.
Galiè N., Manes
A., Palazzini M.,
Negrio L. “Ambrisentan (Volibris): un nuovo passo nell'ipertensione
arteriosa polmonare” Chest, ACCP, 2009 Capitolo
Italiano
51.
M. Palazzini, A. Manes, L. Negro, A. Marinelli,
E. Leci, S. Gambetti, C. Bachetti, E. Beciani, E. Conficoni, A.
Branzi, N. Galiè “L'ipertensione arteriosa polmonare. Parte I:
patobiologia, fisiopatologia, aspetti clinici e
diagnostici”,
G Ital Cardiol (Rome).
2009 May;10(5):271-300
52.
A. Manes, A. Marinelli, M.
Palazzini, L. Negro, E. Leci, S. Gambetti, C. Bachetti, E.
Beciani, E. Conficoni, A. Branzi, N. Galiè “L'ipertensione
arteriosa polmonare. Parte II: terapia medica e chirurgica”,
G Ital Cardiol (Rome).
2009 Jun;10(6):366-81
53.
M. Palazzini, L. Negro, A. Marinelli, E. Leci, E.
Conficoni, A. Manes, A. Branzi, N. Galiè “Genotype to phenotype
analysis in plmonary arterial hypertension” Am J Resp and Crit Care Med
2009,
54.
L. Negro, M. Palazzini, E.
Conficoni, E. Leci, A. Marinelli, A. Manes, A. Branzi, N. Galiè
“Comparison of effects of continuous i.v.epoprostenol alone or in
combination with endothelin receptor antagonists anf
phosphodiesterase-5inhibitors” Am J Resp and CritCare Med 2009,
55.
L. Negro1, M.
Palazzini1, A. Manes1, E. Leci1, E. Conficoni1, A. Marinelli1,
C. Bachetti1, E. Beciani1, A. Branzi1, N. Galie'1. Sildenafil therapy for patients with porto-pulmonary
hypertension and pulmonary arterial hypertension associated with
HIV infection. European Heart Journal 2009;Vol.30(Abstract
Supplement):264
56.
E. Leci1, M.
Palazzini1, A. Manes1, L. Negro1, A. Marinelli1, S. Gambetti1,
E. Beciani1, E. Conficoni1, A. Branzi1, N. Galie'. Sildenafil therapy for both operable and inoperable
chronic thromboembolic pulmonary hypertension. European Heart Journal 2009;Vol.30(Abstract
Supplement):109
57.
A. Manes1, L. Negro1, M.
Palazzini1, A. Marinelli1, E. Leci1, S. Gambetti1, E.
Conficoni1, M.L. Bacchi-Reggiani1, A. Branzi1, N. Galie.
Epidemiology of pulmonary arterial hypertension:
comparison between clinical trials and registries. European Heart Journal 2009;Vol.30(Abstract
Supplement):257
58.
M. Palazzini
, A. Manes. Pulmonary veno-occlusive disease misdiagnosed as
idiopathic pulmonary arteria hypertensione. Eur Respir Rev 2009;
18: 113, 177–180
59.
M. Palazzini, E. Gotti, G. Mazzanti, I. Bulatovic, A. Marinelli, E.
Leci, S. Gambetti, E. Conficoni, C. Bachetti, A. Manes, N.
GalieEffects of medical treatment for operable and
inoperable chronic thromboembolic pulmonary hypertension patients.,
[Publication Page: A1944]. Am J Respir Crit Care Med
181;2010:A1944
60.
M. Palazzini
, E. Gotti, G. Mazzanti, I. Bulatovic, A. Marinelli, E.
Leci, S. Gambetti, E. Conficoni, C. Bachetti, A. Manes, N.
Galie. A randomized open label study comparing bosentan to
sildenafil first-line treatment in pulmonary arterial hypertension
and chronic thromboembolic pulmonary hypertension, [Publication
Page: A3357]. Am J Respir Crit Care Med
181;2010:A3357
61.
E. Beciani, M.
Palazzini, I. Bulatovic, G. Mazzanti, E. Gotti, A. Marinelli,
E. Leci, S. Gambetti, E. Conficoni, C. Bachetti, A. Manes, N.
Galie. Effects of sildenafil treatment in patients with
pulmonary hypertension associated with congenital cardiac shunts,
[Publication Page: A3359]. Am J Respir Crit Care Med
181;2010:A3359
62.
C. Bachetti, M.
Palazzini, E. Gotti, I. Bulatovic, G. Mazzanti, A. Marinelli,
E. Leci, S. Gambetti, A. Manes, E. Conficoni, N. Galie.
Detection of heart structural and functional changes
by Magnetic Resonance after medical therapy in patients with
pulmonary hypertension, [Publication Page: A3406]. Am J Respir Crit
Care Med 181;2010:A3406
63.
E. Leci, M. Palazzini,
E. Gotti, I. Bulatovic, G. Mazzanti, A. Marinelli, A. Manes, S.
Gambetti, E. Beciani, E. Conficoni, C. Bachetti, N. Galie.
Prognostic parameters for survival of patients with
pulmonary arterial hypertension associated to connective tissue
diseases treated with targeted therapy, [Publication Page: A4844].
Am J Respir Crit Care Med 181;2010:A4844
64.
A. Marinelli, M.
Palazzini, S. Gambetti, E. Leci, C. Bachetti, E. Beciani, E.
Conficoni, G. Mazzanti, I. Bulatovic, E. Gotti, A. Manes, N.
Galie. Role of echocardiographic right atrial area in the
prognosis of patients with pulmonary arterial hypertension,
[Publication Page: A4820]. Am J Respir Crit Care Med
181;2010:A4820
65.
S. Gambetti, M.
Palazzini, A. Marinelli, I. Bulatovic, E. Gotti, G. Mazzanti,
E. Beciani, E. Leci, E. Conficoni, C. Bachetti, A. Manes, N.
Galie. Comparative analysis of outcome between idiopatic and
associated to connective tissue diseases pulmonary arterial
hypertension patients, [Publication Page: A4821]. Am J Respir Crit
Care Med 181;2010:A4821
66.
Current era survival of pulmonary arterial
hypertension (PAH) patients: comparison between clinical
sub-groups.
M. Palazzini1
, E. Leci1, C. Bachetti1, E.
Conficoni1, G. Mazzanti1, E.
Gotti1, F. Sgro1, A. Manes1, A.
Branzi1, N. Galie. Eur Heart
J. 2010
67.
Prognostic value of echocardiographic parameters in
patients with pulmonary arterial hypertension (PAH) treated with
targeted therapies.
E. Beciani1, M.
Palazzini1, C. Bachetti1, F.
Sgro1, E. Conficoni1, E. Gotti1,
G. Mazzanti1, A. Manes1, A.
Branzi1, N. Galie1
- Eur Heart J.
2010
68.
A randomized open label study comparing bosentan or
sildenafil first-line treatment in pulmonary arterial hypertension
(PAH) and chronic thromboembolic pulmonary hypertension
(CTEPH).
M. Palazzini1
, E. Leci1, C. Bachetti1, F.
Sgro1, G. Mazzanti1, E. Beciani1,
E. Gotti1, A. Manes1, A. Branzi1,
N. Galie1
- Eur Heart J.
2010
69.
Heart structural and functional changes by Cardiac
Magnetic Resonance (CMR) after targeted medical therapy in patients
with Pulmonary Arterial Hypertension (PAH).
C. Bachetti1, M.
Palazzini1, E. Leci1, E.
Conficoni1, E. Gotti1, G.
Mazzanti1, F. Sgro1, A. Manes1, A.
Branzi1, N. Galie1
- Eur Heart J.
2010
70.
Effects of medical treatment in operable and
inoperable chronic thromboembolic pulmonary hypertension
patients.
E. Leci1, M.
Palazzini1, E. Beciani1, E.
Conficoni1, E. Gotti1, G.
Mazzanti1, F. Sgro1, A. Manes1, A.
Branzi1, N. Galie1
- Eur Heart J.
2010
71.
Galiè N
,
Palazzini M
,
Manes A
. Pulmonary arterial hypertension: from the kingdom of
the near-dead to multiple clinical trial meta-analyses.
Eur Heart
J. 2010 Sep;31(17):2080-6. Epub 2010 May
26.
72.
Galiè N
,
Palazzini M
,
Leci E
,
Manes A
. Current therapeutic approaches to pulmonary arterial
hypertension.
Rev Esp
Cardiol. 2010 Jun;63(6):708-24.
73.
Manes A
,
Palazzini M
,
Galiè N
. [Pulmonary hypertension and the relationships between
hemodynamic-pathophysiologic definitions, echocardiographic
estimate and final clinical diagnosis: clarification is
needed].
G Ital
Cardiol (Rome). 2010 May;11(5):408-11.
74.
Massimiliano Palazzini
, Enri Leci, Cristina Bachetti, Elisa Conficoni, Gaia Mazzanti
Enrico Gotti, Federica Sgrò, Elena Beciani, Alessandra Manes,
Angelo Branzi, Nazzareno Galiè.Current era survival of pulmonary
arterial hypertension (PAH) patients: comparison between clinical
sub-gropus. Giornale italiano di cardiologia. Roma 2010. (1-12)
C53
75.
Elena Beciani, Massimiliano
Palazzini, Enri Leci, Elisa Conficoni, Gaia Mazzanti, Enrico
Gotti, Federica Sgrò, Alessandra Manes, azzurra Fabbrizioli, Angelo
Branzi, Nazzareno Galiè. Combination of sildenafil to bosentan tgerapy in
patients with pulmonary arterial hypertension associated with
congenital heart defects.
Giornale italiano di cardiologia. Roma 2010. (1-12)
P196
76.
Enri Leci, Enrico Gotti, Massimiliano Palazzini,
Elena Beciani, Gaia Mazzanti, Federica Sgrò, Azzurra Fabbrizioli,
Cristina Bachetti, Elisa Conficoni, Alessandra Manes, Angelo
Branzi, Nazzareno Galiè. Effect of Medical treatment in operable and
inoperabile chronic thromboembolic pulmonary hypertension (CTEPH)
patients.
Giornale italiano di cardiologia. Roma 2010. (1-12)
C366
77.
Elisa Conficoni, Enri Leci, Elena Beciani, Massimiliano Palazzini,
Cristina Bachetti, Federica Sgrò, Azzurra Fabbrizioli, Enrico
Gotti, Alessandra Manes, Angelo Branzi, Nazzareno Galiè.
Prognostic value of echocardiographic parameters in
patients with pulmonary arterial hypertension (PAH) treated with
targeted therapies.
Giornale italiano di cardiologia. Roma 2010. (1-12)
C368
78.
Massimiliano Palazzini,
Enri Leci, Cristina Bachetti, Federica Sgrò, Gaia Mazzanti, Elena
Beciani, Enrico Gotti, azzurra Fabbrizioli, Alessandra Manes,
Angelo Branzi, Nazzareno Galiè. A Randomized open label study comparing bosentan or
sildenafil first-line treatment in pulmonary arterial hyupertension
and chronic thromboembolic pulmonary hypertension. Giornale
italiano di cardiologia. Roma 2010. (1-12) C365
79.
Galiè N
,
Palazzini M
,
Manes A
.
Eur Respir J. 2010 Nov;36(5):986-90. Pulmonary hypertension and
pulmonary arterial hypertension: a clarification is
needed.
80.
Palazzini, M.; Hoeper, M.; Sitbon, O.; ,Current pulmonary
hypertension guidelines and remaining controversies,Clinical
research in cardiology
supplements,5,,3-8,2010,Springer
81.
Modolon C, Attinà D, Buia F, De Luca F, Fughelli P, Bacchi Reggiani
ML, Palazzini M, Manes
A, Leci E, Galiè N, Zompatori M. Lung neovascularity in pulmonary
arterial hypertension associated with congenital heart defects and
idiopathic pulmonary arterial hypertension: study of 198
patients. Eur Radiol. 2011 Dec 30.
82.
Beciani, E. Leci, M. Palazzini, C . Bachetti, F. Sciarra, E.
Conficoni, A. Manes, N. Galiè. Am J Respir C rit C are Med 183;2011:A5895.
Combination Of Sildenafil To Bosentan Therapy In Patients With
Pulmonary Arterial Hypertension Associated With Congenital Heart
Defects
83.
F. Sciarra, M. Palazzini, E. Leci, E. Conficoni, F. Sgrò, E.
Beciani, C . Bachetti, G. Mazzanti, E. Gotti, A. Manes, N. Galiè.
Current Era Survival In Patients With Pediatric Pulmonary Arterial
Hypertension. Am J Respir C rit C are Med
183;2011:A5950
84.
E. Leci, M. Palazzini, F. Sciarra, F. Sgrò, E. C onficoni, E.
Beciani, C . Bachetti, A. Manes, N. Galiè. Current Era Survival Of Patients With Pulmonary
Arterial Hypertension (PAH) Associated With Congenital Heart
Disease (CHD). Am J Respir C rit C are Med
183;2011:A6132
85.
C . Bachetti, M. Palazzini, F. Pasquale, E. Beciani,
F. Sciarra, E. C onficoni, E. Leci, F. Sgrò, A. Manes, N.
Galiè, Detection Of Structural And Functional Heart Changes
By Magnetic Resonance After Medical Therapy In Patients With
Pulmonary Arterial Hypertension. Am J Respir C rit C are Med
183;2011:A4993
86.
E. Leci, M. Palazzini, E. Beciani, E. C onficoni, F. Sgrò, F.
Sciarra, C . Bachetti, A. Manes, N. Galiè. Effects Of S.C.
Treprostinil On Top Of Double Oral Combination Therapy In Patients
With Pulmonary Arterial Hypertensione (PAH) And Inoperable Chronic
Thromboembolic Pulmonary Hypertension (CTEPH) Am J Respir C rit C
are Med 183;2011:A2416
87.
M. Palazzini, F. Sgrò, C . Bachetti, E. Beciani, E. Leci, E. C
onficoni, E. Gotti, G. Mazzanti, A. Manes, N. Galiè. Genotype To Phenotype Correlations In Heritable
Pulmonary Arterial Hypertension (PAH). Am J Respir C rit C are Med
183;2011:A5504
88.
M. Palazzini, E. Leci, C . Bachetti, E. Beciani, F. Sgrò, F.
Sciarra, E. Gotti, E. C onficoni, G. Mazzanti, A. Manes, N.
Galiè. ESC-ERS 2009 Pulmonary Hypertension Guidelines: An
Evaluation Study In 9 European Countries (The Guide To PH Study).
Am J Respir C rit C are Med 183;2011:A1920
89.
N. Rizzo1,
M. Palazzini1
, E. Leci1, A. Manes1, F. Sgro'1, F. Sciarra1, C. Bachetti1, E.
Beciani1, A. Branzi1, N. Galie'1. 1Institute of Cardiology, University of Bologna,
Bologna, ItalySildenafil therapy for patients with porto-pulmonary
hypertension and pulmonary arterial hypertension associated with
HIV infection. European Heart Journal 2011;Vol.32(Abstract
Supplement):173
90.
F. Terzi1, F. Sgro'1, E. Leci1, M. Palazzini1, C. Bachetti1, E.
Conficoni1, A. Manes1, E. Beciani1, A. Branzi1, N. Galie'1.
1Institute of Cardiology, University of Bologna,
Bologna, Italy.Genotype to phenotype correlations in heritable
pulmonary arterial hypertension. European Heart Journal
2011;Vol.32(Abstract Supplement):433
91.
E. Leci1, M. Palazzini1, F. Sgro'1, A. Manes1, E. Conficoni1, E.
Beciani1, C. Bachetti1, E. Gotti1, A. Branzi1, N. Galie'.
ESC-ERS 2009 pulmonary hypertension guidelines: an
evaluation study in 9 European countries (the guide to PH study).
European Heart Journal 2011;Vol.32(Abstract
Supplement):676
92.
S. Cantoni1, R. Tassinari1, M. Galletti1, C. Cavallini1, A.
Guffanti1, G. Mazzanti1, M. Palazzini1, A. Manes1, N. Galie'1, C.
Ventura. Baseline difference in transcriptional patterns
between PAH patients and normal volunteers. European Heart Journal 2011;Vol.32(Abstract
Supplement):504
93.
M. Palazzini1, E. Leci1, F. Sciarra1, E. Conficoni1, A. Manes1, E.
Beciani1, C. Bachetti1, F. Sgro'1, A. Branzi1, N. Galie'1.
Current era survival of patients with pulmonary
arterial hypertension (PAH) associated with congenital heart
disease (CHD). European Heart Journal 2011;Vol.32(Abstract
Supplement):174
94.
F. Sciarra1, E. Leci1, M. Palazzini1, E. Conficoni1, F. Sgro'1, E.
Beciani1, C. Bachetti1, A. Manes1, A. Branzi1, N. Galie'1.
1Institute of Cardiology, University of Bologna,
Bologna, Italy. Current era survival in patients with
pediatric pulmonary arterial hypertension. European Heart Journal
2011;Vol.32(Abstract Supplement):649
95.
E. Conficoni1, E. Leci1, M. Palazzini1, G. Mazzanti1, N. Rizzo1, E.
Gotti1, A. Manes1, F. Sgro'1, A. Branzi1, N. Galie'1. Effects of s.c. treprostinil on top of double oral
combination therapy in patients with pulmonary arterial
hypertensione (PAH) and inoperable chronic thromboembolic pulmonary
hypertension (CTEPH). European Heart Journal 2011;Vol.32(Abstract
Supplement):173
96.
M. Palazzini. Analisi dei fattori prognostici e della risposta al
trattamento nei pazienti con ipertensione arteriosa polmonare. Tesi
di dottorato, Bologna, 2011
Gene Expression Profiling In Peripheral Blood Mononuclear Cells Of
Patients With Idiopathic And Heritable Pulmonary Arterial
Hypertension, [Publication Page: A1885] S. Cantoni, Pharmaceutical
Chemistry and Tec1, R. Tassinari, Bsc1, M. Galletti, PhD1, A.
Guffanti, PhD2, E. Brini, PhD2, M. Palazzini, Medical Doctor1, A.
Manes, Md1, C. Ventura, Md1, N. Galiè, Md1. Am J Respir Crit Care
Med 185;2012:A1885
97.
M. Palazzini, E. Leci, F. Dardi, A. Rinaldi, A.
D'Adamo, F. Terzi, C. Bachetti, E. Beciani, F. Sciarra, E.
Conficoni, N. Rizzo, E. Gotti, G. Mazzanti, A. Manes, N. Galie,
Current Era Survival In Patients With Pediatric Pulmonary Arterial
Hypertension, [Publication Page: A1898]. Am J Respir Crit Care Med
185;2012:A1898
98.
F. Terzi, M. Palazzini, E. Leci, F. Dardi, A. Rinaldi, A. D'Adamo,
C. Bachetti, E. Conficoni, G. Mazzanti, E. Beciani, E. Gotti, A.
Manes, N. Galie, Prof. “Effects Of Medical Treatment For Operable And
Inoperable Chronic Thromboembolic Pulmonary Hypertension,
[Publication Page: A3837]”. Am J Respir Crit Care Med
185;2012:A3837
99.
E. Leci, M. Palazzini, F. Dardi, A. Rinaldi, , A. D'Adamo, F.
Terzi, C. Bachetti, E. Beciani, F. Sciarra, E. Conficoni, E. Gotti,
G. Mazzanti, A. Manes, N. Galie. Effect Of Medical Therapy In Patients With
Out-Of-Proportion Pulmonary Hypertension Due To Parenchimal Lung
Disease, [Publication Page: A4104]. Am J Respir Crit Care Med
185;2012:A4104
100.
G. Mazzanti, M. Palazzini, E. Leci, F. Dardi, A. Rinaldi, A.
D'Adamo, F. Terzi, E. Gotti, C. Bachetti, E. Beciani, E. Conficoni,
F. Sciarra, A. Manes, N. Galie. A Randomized Open Label Study Comparing First-Line
Treatment With Bosentan Or Sildenafil In Pulmonary Arterial
Hypertension, [Publication Page: A4105]. Am J Respir Crit Care Med
185;2012:A4105
101.
E. Conficoni,
M. Palazzini
, E. Leci, A. Rinaldi, C. Bachetti, F. Terzi, F. Sciarra, E.
Beciani, N. Rizzo, F. Dardi, E. Gotti, G. Mazzanti, A. D'Adamo, A.
Manes, N. Galie. Effects Of Long-Term Administration Of Epoprostenol
Alone Or In Combination With Endothelin Receptor Antagonists And
Phosphodiesterase Type-5 Inhibitors, [Publication Page: A4799]. Am
J Respir Crit Care Med 185;2012:A4799
102.
E. Leci, F. Dardi, M. Palazzini, A. Rinaldi, A. D'Adamo, E. Conficoni, E. Beciani,
C. Bachetti, F. Terzi, F. Sciarra, E. Gotti, G. Mazzanti, A. Manes,
N. Galiè. Sildenafil Therapy In Patients With Porto-Pulmonary
Hypertension, [Publication Page: A4814]. Am J Respir Crit Care Med
185;2012:A4814
103.
Manes A, Palazzini M, Dardi F, D'Adamo A, Rinaldi A, Galiè N.
[Female gender and pulmonary arterial hypertension: a complex
relationship]. G Ital Cardiol (Rome). 2012 Jun;13(6):448-60. doi:
10.1714/1073.11764.
104.
G. Mazzanti, M. Palazzini, A. Albini, F. Terzi, C. Bachetti,
E.Conficoni, E. Monti, E. Gotti, N. Rizzo, F. Dardi, A. Rinaldi, A.
Manes, N. Galie. A Randomized Open Label Study Comparing First-Line
Treatment With Bosentan Or Sildenafil In Pulmonary Arterial
Hypertension (PAH): Long-Term Results, [Publication Page: A3535] Am
J Respir Crit Care Med 187;2013:A3535
105.
C. Bachetti, M. Palazzini, E. Monti, A. Albini, F. Dardi, A.
Rinaldi, G. Mazzanti, E. Gotti, E. Conficoni, N. Rizzo, F. Terzi,
A. Manes, N. Galiè, . Efficacy And Safety Of Up-Front Combination Therapy,
[Publication Page: A3277] Am J Respir Crit Care Med
187;2013:A3277
106.
F. Terzi, M. Palazzini, C. Bachetti, A. Albini, E. Monti, E. Gotti, G.
Mazzanti, E. Conficoni, F. Dardi, A. Rinaldi, N. Rizzo, A. Manes,
N. Galie. Genotype To Phenotype Correlations In Heritable
Pulmonary Arterial Hypertension, [Publication Page: A5367]. Am J
Respir Crit Care Med 187;2013:A5367
107.
Alessandra Manes, Massimiliano Palazzini, Enri Leci, Maria L Bacchi
Reggiani, Angelo Branzi, Nazzareno Galiè. Current era survival of patients with pulmonary
arterial hypertension associated with congenital heart disease: a
comparison between clinical subgroups. European heart journal. Eur
Heart J. 2013 Mar 1. [Epub ahead of print]
108.
Domenico Attinà, Fabio Niro, Patrick Tchouanté,
Giangaspare Mineo, Vincenzo Russo, Massimiliano Palazzini,
Nazzareno Galiè, Stefano Fanti, Luigi Lovato, Maurizio Zompatori.
Pulmonary artery intimal sarcoma. Problems in the differential
diagnosis. La radiologia medica. Pag.1-10. Springer
Milano
109.
Maurizio Zompatori, Maria Barbara Leone, Marica Giannotta,
Nazzareno Galiè, Massimiliano Palazzini, Maria Letizia Bacchi
Reggiani, Lea Bono, Gian Stefano Pollini. Pulmonary hypertension and systemic sclerosis: the
role of high resolution computed tomography. La radiologia medica.
Pag.1-13. Springer Milano
110.
Rossi A, Zompatori M, Tchouante
Tchouanhou P, Amadori M, Palazzini M, Conficoni E, Galiè N, Poletti
V, Gavelli G. Rare causes of pulmonary hypertension: spectrum of
radiological findings and review of the literature.
Radiol Med. 2013 Nov 15.
111.
Mineo G, Attinà D, Mughetti M, Balacchi C, De Luca F, Niro F,
Ciccarese F, Lovato L, Russo V, Buia F, Modolon C, Manes A,
Palazzini M, Galiè N, Zompatori M.
Pulmonary veno-occlusive disease: the role of CT. Radiol Med. 2013
Dec 3. [Epub ahead of print]
112.
Treatment goals of pulmonary
hypertension. McLaughlin VV1, Gaine SP2, Howard LS3, Leuchte HH4,
Mathier MA5, Mehta S6, Palazzini M7, Park MH8, Tapson VF9, Sitbon
O. J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D73-81. doi:
10.1016/j.jacc.2013.10.034.
LIST OF PUBLICATIONS
VOLUME-ASSAY
1.
GALIE' N, MANES A, PALAZZINI M, LECI E
(2011). Conventional Medical Therapies in the treatment of
pulmonary hypertension. In: PEACOCK A NAEIJE R RUBIN L. Pulmonary
Hypertension. p. 303-313, LONDON:Hadder Arnold, ISBN:
9780340981924
2.
GALIE' N, MANES A, PALAZZINI M (2011).
Pulmonary Hypertension: Lessons from Adults. In:
BEGHETTI M. Pediatric Pulmonary Hypertension. p. 1-5,
MUNICH:Elsevier.
3.
GALIE' N, MANES A, PALAZZINI M., LECI E
(2011). Pulmonary hypertension. In: TUBARO M. The ESC
Textbook of Acute and Intensive cardiac care. p. 650-659,
OXFORD:Oxford University Press. ISBN: 978-0-19-958431-4
4.
De Juli E, Galie N, Manes A, Palazzini M, Ziglio G
(2010). Ipertensione arteriosa polmonare. In: Manuale di Terapia
Cardiovascolare. p. 1191-1205, Roma: Il Pensiero Scientifico, ISBN:
978-88-490-0337-6
